Other injuries involving multiple body regions, not elsewhere classified

ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T06 Cause of death: ICD-10 — T06 2 out of 7 registries used, show all original rules.	55
4. Check minimum number of events None	55
5. Include endpoints None	55
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T0[0-7]
Name in latin: Aliae laesiones regionum multarum non alibi classificatae

NAME	ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T06
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T06
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other injuries involving multiple body regions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	32	23
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	48.57	43.61	55.47

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529406) Shigella sp [Presence] in Stool by Culture

7.31

2.94

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

7.31

2.94

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

7.31

2.94

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.70

2.89

3.1

2.8

—

(3025941) Bacteria identified in Stool by Culture

4.27

2.82

1.1

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4.49

2.68

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

128

2.37

2.38

5.1

3.3

0.00

estimate

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

213

2.20

2.10

4.8

4.1

—

(3020891) Body temperature

4.46

1.86

1.4

2.9

—

(3023368) Bacteria identified in Blood by Culture

2.22

1.85

6.6

4.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.19

1.79

2.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3.19

1.79

3.1

3.7

5.56

4.83

kpa

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

0.00

1.60

0.0

2.5

—

28.19

—

(3044640) Blood type and Crossmatch panel - Blood

148

1.95

1.54

2.1

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.80

1.41

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.25

1.38

5.6

5.4

—

(3009261) Glucose [Presence] in Urine by Test strip

227

1.84

1.36

5.0

3.7

0.00

estimate

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.79

1.24

1.2

3.0

1.46

1.40

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.79

1.24

1.2

3.0

0.54

0.78

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

140

1.81

1.22

2.2

2.7

—

(3032080) INR in Blood by Coagulation assay

168

1.76

1.18

10.7

8.0

1.23

1.17

inr

—

(40761535) Cells panel - Urine sediment

2.52

1.17

1.4

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

226

1.72

1.13

5.7

5.2

0.00

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

228

1.69

1.08

5.0

3.4

0.00

estimate

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.40

1.05

1.2

4.6

64.02

47.78

—

(3042936) Bacteria identified in Isolate by Culture

2.00

1.05

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

113

1.73

0.97

1.5

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

168

1.63

0.93

2.0

1.7

108.37

98.61

pmol/l

0.66

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

187

1.62

0.92

5.0

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

126

1.64

0.84

2.6

2.2

146.06

183.58

u/l

0.35

118

(3003694) ABO and Rh group [Type] in Blood

127

1.62

0.82

1.3

1.6

—

(3012544) pH of Venous blood

1.96

0.77

1.1

4.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

177

1.51

0.71

4.3

3.3

25.92

19.58

ng/l

0.40

112

(3007164) IgA [Mass/volume] in Serum or Plasma

1.61

0.70

1.1

1.4

2.78

2.11

g/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.79

0.65

11.4

10.7

8.40

9.43

mmol/l

—

(3017732) Neutrophils [#/volume] in Blood

1.79

0.65

2.6

2.5

4.35

3.69

e9/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

308

1.49

0.64

6.0

3.9

—

(4010399)

1.73

0.63

1.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.63

0.62

3.1

2.1

—

(1761868) Lipid panel - Serum or Plasma

187

0.66

0.59

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.57

0.57

1.9

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.63

0.57

3.1

1.9

—

(3022096) Basophils/100 leukocytes in Blood

217

0.69

0.56

3.4

5.6

0.75

0.65

0.26

198

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

110

1.50

0.56

1.9

2.3

—

(36660697) Celiac disease serology panel - Serum

1.65

0.56

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

147

1.45

0.55

3.8

3.1

7.11

61.30

e6/l

1.11

101

(3000492) Spirometry study

1.56

0.53

1.5

1.4

—

(3015736) pH of Urine

186

1.41

0.53

3.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

103

1.48

0.52

1.4

1.3

1.36

1.04

u/ml

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.60

0.51

3.0

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

444

0.70

0.45

5.5

4.1

4.64

4.73

mmol/l

0.31

414

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.47

0.44

1.5

—

(3026008) Bacteria identified in Urine by Culture

116

1.40

0.43

3.9

2.8

—

(40768797) Stomach Pathology biopsy report

1.39

0.42

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.42

0.0

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

0.00

0.42

0.0

7.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.41

0.0

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.41

0.0

1.5

—

(3044889) 12 lead EKG panel

302

1.33

0.40

4.6

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.44

0.36

5.5

3.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.39

0.30

1.8

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

125

0.76

0.26

4.3

4.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.22

0.26

2.4

2.2

2.40

2.45

mmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

333

1.23

0.24

2.9

3.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.27

0.23

1.0

1.4

—

(40768804) Tissue Pathology biopsy report

185

0.81

0.23

1.8

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.21

0.22

2.2

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

0.88

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

33.54

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.21

0.0

3.8

—

31.07

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(4094501)

0.00

0.21

0.0

1.0

—

(3000494) Fungus identified in Specimen by Culture

1.22

0.20

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.20

0.0

1.3

—

(3013512) EKG study

110

1.24

0.19

4.4

4.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.21

0.19

2.4

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

0.73

0.18

4.4

2.5

12.98

14.41

umol/l

—

(3037522) Nuclear Ab [Titer] in Serum

1.19

0.17

1.1

1.5

—

365.00

—

(40758558) Short blood count panel - Blood

102

1.23

0.17

5.5

7.0

—

(3006504) Eosinophils/100 leukocytes in Blood

221

0.85

0.16

3.5

5.7

2.18

2.50

0.38

203

(46235355) HIV 1 and 2 tests - Meaningful Use set

123

1.19

0.14

2.9

1.9

—

(36304419) Bacteria [Presence] in Urine

114

1.18

0.13

2.9

2.6

—

(40761536) Microorganisms panel - Urine sediment

1.10

0.10

3.2

3.9

—

(42870588) Differential panel, method unspecified - Blood

146

1.14

0.09

2.7

5.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

443

0.87

0.09

16.5

11.0

88.19

85.96

ml/min/173m2

0.23

349

(21494755) Public health laboratory ask at order entry panel

0.79

0.09

1.0

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

487

1.29

0.08

19.4

14.1

85.88

77.12

umol/l

0.42

487

(3023103) Potassium [Moles/volume] in Serum or Plasma

460

1.15

0.07

22.0

13.4

4.02

3.96

mmol/l

0.76

445

(3002030) Lymphocytes/100 leukocytes in Blood

229

0.93

0.03

3.4

5.7

28.50

27.70

0.15

211

(3009542) Hematocrit [Volume Fraction] of Blood

428

0.92

0.03

18.2

13.5

39.78

40.37

0.16

330

(3041096) Erythrocytes [Presence] in Urine by Automated

142

1.08

0.03

5.3

3.6

—

(3013115) Eosinophils [#/volume] in Blood

237

0.95

0.01

4.3

6.0

0.16

0.17

e9/l

0.16

213

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

146

0.94

0.01

3.1

2.8

49.07

34.56

u/l

0.33

133

(3021589) Normoblasts [#/volume] in Blood

189

1.01

0.00

10.6

10.2

0.00

e9/l

0.00

155

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

103

0.96

0.00

2.6

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

223

0.98

0.00

3.3

5.5

58.13

57.77

0.07

208

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.06

0.00

2.0

1.8

2.72

mg/l

—

(3019198) Lymphocytes [#/volume] in Blood

235

0.96

0.00

4.3

5.7

1.75

1.77

e9/l

0.04

213

(3006315) Basophils [#/volume] in Blood

226

1.03

0.00

4.3

5.8

0.03

0.04

e9/l

0.68

201

(3019069) Monocytes/100 leukocytes in Blood

222

0.98

0.00

3.9

6.0

7.97

8.82

0.60

205

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

5.5

—

3.71

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

1.7

—

2.25

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.52

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

5.5

—

58.13

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

5.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3022145) Colonoscopy Study observation

1.00

0.00

1.2

1.3

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

1.0

—

8.00

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

0.79

—

(3021788) Differential panel - Synovial fluid

0.00

0.0

1.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

1.8

—

53.00

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

3.68

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

2.3

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.0

—

15.02

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.0

1.4

—

0.18

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.00

0.00

2.0

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.6

—

(4268621)

0.00

0.0

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

3.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

22.71

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

462

1.12

0.00

21.0

13.2

139.91

139.64

mmol/l

0.39

449

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

2.64

—

(4306422)

0.00

0.0

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.87

0.00

2.0

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.4

—

4.57

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED – Other injuries involving multiple body regions, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other injuries involving multiple body regions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other injuries involving multiple body regions, not elsewhere classified (ST19_OTHER_INJURI_INVOLVI_MULTIPLE_BODY_REGIONS_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints